Antonio Galvano

Antonio Galvano

Università degli Studi di Palermo - Palermo / Italy
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 915865
University of Palermo
person_outline Antonio Galvano's MOST POPULAR ARTICLES
1-) PD-L1 expression as predictive biomarker in patients with NSCLC: a pooled analysisF Passiglia, G Bronte, V Bazan, C Natoli, S Rizzo, A Galvano, A Listì, ...Oncotarget 7 (15), 19738, 20161462016
2-) Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Outcomes with Nivolumab in Pretreated Non-Small Cell Lung Cancer (NSCLC): A Large Retrospective …A Russo, M Russano, T Franchina, MR Migliorino, G Aprile, G Mansueto, ...Advances in Therapy 37 (3), 1145-1155, 20201252020
3-) Triple negative breast cancer: shedding light onto the role of pi3k/akt/mtor pathwayD Massihnia, A Galvano, D Fanale, A Perez, M Castiglia, L Incorvaia, ...Oncotarget 7 (37), 60712, 20161232016
4-) Programmed death ligand 1 (PD-L1) as a predictive biomarker for pembrolizumab therapy in patients with advanced non-small-cell lung cancer (NSCLC)L Incorvaia, D Fanale, G Badalamenti, N Barraco, M Bono, LR Corsini, ...Advances in therapy, 1-18, 20191202019
5-) The significance of epidermal growth factor receptor uncommon mutations in non-small cell lung cancer: A systematic review and critical appraisalV Gristina, U Malapelle, A Galvano, P Pisapia, F Pepe, C Rolfo, S Tortorici, ...Cancer Treatment Reviews, 101994, 20201182020